Empfehlung
29,5
Verkaufen
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
95
100 neu, 289 erhöht, 2256,3M $ netto
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,72% (Stand: 28.02.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
Stammdaten
Unternehmen
| Name | BECTON DICKINSON & CO |
|---|---|
| Ticker | BDX |
| CIK | 0000010795 |
Branche
| SIC-Code | 3841 |
|---|---|
| Beschreibung | Surgical & Medical Instruments & Apparatus |
Wertpapier
| CUSIP | 075887109 |
|---|---|
| ISIN | US0758871091 |
| Typ | Common Stock |
| Titel | Becton Dickinson & Co |
Status
| Zuletzt geprüft | 2026-03-23 11:12:03.852859 |
|---|
Fondsaktivität (letzte 3 Quartale)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 36,678,939 | 32,455,790 | 4,223,149 | 7,118,281,692 | Aufgestockt | +13,0% | |
| BlackRock, Inc. | 27,648,705 | 27,752,308 | -103,603 | 5,365,784,238 | Reduziert | -0,4% | |
| STATE STREET CORP | 13,989,132 | 13,872,395 | 116,737 | 2,714,870,847 | Aufgestockt | +0,8% | |
| First Eagle Investment Management, LLC | 11,646,000 | 9,994,408 | 1,651,592 | 2,260,139,284 | Aufgestockt | +16,5% | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 9,486,694 | 9,150,584 | 336,110 | 1,841,082,704 | Aufgestockt | +3,7% | |
| GEODE CAPITAL MANAGEMENT, LLC | 6,885,361 | 6,831,477 | 53,884 | 1,331,164,666 | Aufgestockt | +0,8% | |
| Blackstone Inc. | 6,462 | 0 | 6,462 | 1,209,493,000 | Neu | +100,0% | |
| FRANKLIN RESOURCES INC | 5,472,003 | 6,943,604 | -1,471,601 | 1,061,951,604 | Reduziert | -21,2% | |
| WELLINGTON MANAGEMENT GROUP LLP | 5,299,030 | 5,232,086 | 66,944 | 1,028,382,752 | Aufgestockt | +1,3% | |
| Clearbridge Investments, LLC | 4,092,337 | 4,406,987 | -314,650 | 794,199,928 | Reduziert | -7,1% | |
| Invesco Ltd. | 3,790,490 | 2,552,983 | 1,237,507 | 735,620,464 | Aufgestockt | +48,5% | |
| NORGES BANK | 3,783,792 | 3,793,193 | -9,401 | 734,320,513 | Reduziert | -0,2% | |
| JPMORGAN CHASE & CO | 3,499,218 | 5,293,383 | -1,794,165 | 679,093,485 | Reduziert | -33,9% | |
| MORGAN STANLEY | 3,374,640 | 3,466,741 | -92,101 | 654,916,597 | Reduziert | -2,7% | |
| AMERICAN CENTURY COMPANIES INC | 3,129,651 | 3,253,599 | -123,948 | 607,371,852 | Reduziert | -3,8% | |
| Veritas Asset Management LLP | 2,874,579 | 2,954,898 | -80,319 | 557,869,547 | Reduziert | -2,7% | |
| HARRIS ASSOCIATES L P | 2,841,721 | 3,115,375 | -273,654 | 551,492,794 | Reduziert | -8,8% | |
| BANK OF AMERICA CORP /DE/ | 2,813,314 | 2,699,263 | 114,051 | 545,979,796 | Aufgestockt | +4,2% | |
| NORDEA INVESTMENT MANAGEMENT AB | 2,773,058 | 3,231,514 | -458,456 | 541,328,651 | Reduziert | -14,2% | |
| NORTHERN TRUST CORP | 2,504,289 | 2,576,184 | -71,895 | 486,007,365 | Reduziert | -2,8% | |
| DIMENSIONAL FUND ADVISORS LP | 2,405,430 | 2,341,970 | 63,460 | 466,857,642 | Aufgestockt | +2,7% | |
| Longview Partners (Guernsey) LTD | 2,160,601 | 2,271,483 | -110,882 | 419,307,836 | Reduziert | -4,9% | |
| First Pacific Advisors, LP | 1,951,246 | 936,257 | 1,014,989 | 378,678,311 | Aufgestockt | +108,4% | |
| Legal & General Group Plc | 1,930,445 | 1,919,404 | 11,041 | 374,641,462 | Aufgestockt | +0,6% | |
| GOLDMAN SACHS GROUP INC | 1,626,922 | 1,843,775 | -216,853 | 315,736,783 | Reduziert | -11,8% | |
| BARCLAYS PLC | 1,602,030 | 662,293 | 939,737 | 310,905,960 | Aufgestockt | +141,9% | |
| FMR LLC | 1,532,988 | 1,004,755 | 528,233 | 297,507,022 | Aufgestockt | +52,6% | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1,496,658 | 0 | 1,496,658 | 290,456,419 | Neu | +100,0% | |
| MARSHALL WACE, LLP | 1,457,212 | 3,703 | 1,453,509 | 282,801,131 | Aufgestockt | +39252,2% | |
| UBS Group AG | 1,293,352 | 1,136,673 | 156,679 | 251,000,823 | Aufgestockt | +13,8% | |
| WELLS FARGO & COMPANY/MN | 1,252,270 | 1,436,281 | -184,011 | 243,027,992 | Reduziert | -12,8% | |
| BRANDES INVESTMENT PARTNERS, LP | 1,229,707 | 1,152,603 | 77,104 | 238,651,416 | Aufgestockt | +6,7% | |
| COOKE & BIELER LP | 1,126,471 | 885,798 | 240,673 | 218,614,227 | Aufgestockt | +27,2% | |
| FIDUCIARY MANAGEMENT INC /WI/ | 1,103,441 | 1,190,188 | -86,747 | 214,144,795 | Reduziert | -7,3% | |
| AQR CAPITAL MANAGEMENT LLC | 1,033,860 | 0 | 1,033,860 | 190,623,107 | Neu | +100,0% | |
| DEUTSCHE BANK AG\ | 952,416 | 751,076 | 201,340 | 184,835,374 | Aufgestockt | +26,8% | |
| HSBC HOLDINGS PLC | 940,908 | 612,191 | 328,717 | 183,161,363 | Aufgestockt | +53,7% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 902,187 | 590,787 | 311,400 | 175,087,431 | Aufgestockt | +52,7% | |
| JARISLOWSKY, FRASER Ltd | 935,130 | 941,803 | -6,673 | 175,028,282 | Reduziert | -0,7% | |
| ProShare Advisors LLC | 901,808 | 971,263 | -69,455 | 175,013,878 | Reduziert | -7,2% | |
| Kovitz Investment Group Partners, LLC | 924,571 | 924,802 | -231 | 173,051,537 | Reduziert | 0,0% | |
| Focus Partners Wealth | 884,056 | 53,046 | 831,010 | 171,525,815 | Aufgestockt | +1566,6% | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 839,854 | 370,008 | 469,846 | 162,990,466 | Aufgestockt | +127,0% | |
| Swiss National Bank | 785,502 | 826,202 | -40,700 | 152,442,373 | Reduziert | -4,9% | |
| RAYMOND JAMES FINANCIAL INC | 765,381 | 936,366 | -170,985 | 148,537,402 | Reduziert | -18,3% | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 735,888 | 883,172 | -147,284 | 142,813,784 | Reduziert | -16,7% | |
| DAVENPORT & Co LLC | 614,002 | 644,701 | -30,699 | 119,454,130 | Reduziert | -4,8% | |
| BRISTOL JOHN W & CO INC /NY/ | 577,531 | 589,386 | -11,855 | 112,081,442 | Reduziert | -2,0% | |
| BNP PARIBAS FINANCIAL MARKETS | 575,371 | 305,584 | 269,787 | 111,662,250 | Aufgestockt | +88,3% | |
| EVERETT HARRIS & CO /CA/ | 550,894 | 549,492 | 1,402 | 106,911,904 | Aufgestockt | +0,3% |
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-26 | Feld Michael | Officer, EVP, Chief Revenue Officer | Open Market Sale | -75 | 156.83 | -11,762.25 | -8,9% | |
| 2026-02-26 | Feld Michael | Officer, EVP, Chief Revenue Officer | Open Market Sale | -75 | 181.84 | -13,638.00 | -10,3% | |
| 2026-02-26 | Feld Michael | Officer, EVP, Chief Revenue Officer | Open Market Sale | -75 | 181.84 | -13,638.00 | -10,3% | |
| 2026-02-18 | SCOTT BERTRAM L | Director | Open Market Sale | -953 | 182.61 | -174,027.33 | -131,5% | |
| 2026-02-18 | SCOTT BERTRAM L | Director | Open Market Sale | -953 | 182.61 | -174,027.33 | -131,5% | |
| 2026-01-26 | Feld Michael | Officer, EVP, CRO & Pres. Life Sciences | Open Market Sale | -75 | 202.73 | -15,204.75 | -11,5% | |
| 2026-01-26 | Feld Michael | Officer, EVP, CRO & Pres. Life Sciences | Open Market Sale | -75 | 202.73 | -15,204.75 | -11,5% | |
| 2026-01-15 | Garrison Michael David | Officer, EVP & Pres Med.Essntl&BioPharm | Open Market Sale | -1,010 | 206.54 | -208,605.40 | -157,6% | |
| 2026-01-15 | Garrison Michael David | Officer, EVP & Pres Med.Essntl&BioPharm | Open Market Sale | -600 | 209.00 | -125,400.00 | -94,8% | |
| 2026-01-15 | Garrison Michael David | Officer, EVP & Pres Med.Essntl&BioPharm | Open Market Sale | -600 | 209.00 | -125,400.00 | -94,8% | |
| 2026-01-15 | Garrison Michael David | Officer, EVP & Pres Med.Essntl&BioPharm | Open Market Sale | -1,010 | 206.54 | -208,605.40 | -157,6% | |
| 2025-12-26 | Feld Michael | Officer, EVP, CRO & Pres. Life Sciences | Open Market Sale | -74 | 196.08 | -14,509.92 | -11,0% | |
| 2025-12-26 | Feld Michael | Officer, EVP, CRO & Pres. Life Sciences | Open Market Sale | -74 | 196.08 | -14,509.92 | -11,0% | |
| 2025-12-17 | Garrison Michael David | Officer, EVP & Pres Med.Essntl&BioPharm | Open Market Sale | -629 | 196.03 | -123,302.87 | -93,2% | |
| 2025-12-17 | Garrison Michael David | Officer, EVP & Pres Med.Essntl&BioPharm | Open Market Sale | -629 | 196.03 | -123,302.87 | -93,2% | |
| 2025-12-01 | Feld Michael | Officer, EVP, CRO & Pres. Life Sciences | Open Market Sale | -75 | 193.36 | -14,502.00 | -11,0% | |
| 2025-12-01 | Feld Michael | Officer, EVP, CRO & Pres. Life Sciences | Open Market Sale | -75 | 193.36 | -14,502.00 | -11,0% | |
| 2025-11-07 | SCOTT BERTRAM L | Director | Open Market Sale | -217 | 176.58 | -38,317.86 | -29,0% | |
| 2025-11-07 | SCOTT BERTRAM L | Director | Open Market Sale | -217 | 176.58 | -38,317.86 | -29,0% | |
| 2025-10-27 | Feld Michael | Officer, EVP & President, Life Sciences | Open Market Sale | -57 | 186.01 | -10,602.57 | -8,0% | |
| 2025-10-27 | Feld Michael | Officer, EVP & President, Life Sciences | Open Market Sale | -57 | 186.01 | -10,602.57 | -8,0% | |
| 2025-09-26 | Feld Michael | Officer, EVP & President, Life Sciences | Open Market Sale | -58 | 181.03 | -10,499.74 | -7,9% | |
| 2025-09-26 | Feld Michael | Officer, EVP & President, Life Sciences | Open Market Sale | -58 | 181.03 | -10,499.74 | -7,9% | |
| 2025-09-10 | Fraser Claire | Director | Open Market Sale | -917 | 187.50 | -171,937.50 | -129,9% | |
| 2025-08-22 | Feld Michael | Officer, EVP & President, Life Sciences | Open Market Sale | -57 | 197.99 | -11,285.43 | -8,5% | |
| 2025-08-22 | Feld Michael | Officer, EVP & President, Life Sciences | Open Market Sale | -57 | 197.99 | -11,285.43 | -8,5% | |
| 2025-08-11 | HAYES GREGORY | Director | Open Market Purchase | 5,250 | 191.57 | 1,005,742.50 | +760,0% | |
| 2025-08-11 | HAYES GREGORY | Director | Open Market Purchase | 5,250 | 191.57 | 1,005,742.50 | +760,0% | |
| 2025-08-08 | Fraser Claire | Director | Open Market Sale | -863 | 192.30 | -165,954.90 | -125,4% | |
| 2025-07-18 | Garrison Michael David | Officer, EVP & President, Medical | Open Market Sale | -1,184 | 180.29 | -213,463.36 | -161,3% | |
| 2025-07-18 | Garrison Michael David | Officer, EVP & President, Medical | Open Market Sale | -1 | 181.50 | -181.50 | -0,1% | |
| 2025-07-18 | Garrison Michael David | Officer, EVP & President, Medical | Open Market Sale | -1 | 181.50 | -181.50 | -0,1% | |
| 2025-07-18 | Garrison Michael David | Officer, EVP & President, Medical | Open Market Sale | -1,184 | 180.29 | -213,463.36 | -161,3% | |
| 2025-06-02 | Shan David | Officer, EVP and Chief ISC Officer | Open Market Sale | -1,166 | 171.19 | -199,607.54 | -150,8% | |
| 2025-06-02 | Shan David | Officer, EVP and Chief ISC Officer | Open Market Sale | -1,166 | 171.19 | -199,607.54 | -150,8% | |
| 2025-04-09 | Garrison Michael David | Officer, EVP & President, Medical | Open Market Sale | -479 | 197.28 | -94,497.12 | -71,4% | |
| 2025-04-09 | Garrison Michael David | Officer, EVP & President, Medical | Open Market Sale | -479 | 197.28 | -94,497.12 | -71,4% |
Fail-to-Deliver (6 Monate)
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-02-24 | 255 | 184,34 | 47.007 |
| 2026-02-23 | 2.039 | 185,39 | 378.010 |
| 2026-02-20 | 1.321 | 182,47 | 241.043 |
Top-Fondshalter (aktuelles Quartal)
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| VANGUARD GROUP INC | 36,678,939 | 7,118,281,692 | 17.62 |
| BlackRock, Inc. | 27,648,705 | 5,365,784,238 | 13.28 |
| STATE STREET CORP | 13,989,132 | 2,714,870,847 | 6.72 |
| First Eagle Investment Management, LLC | 11,646,000 | 2,260,139,284 | 5.59 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 9,486,694 | 1,841,082,704 | 4.56 |
| GEODE CAPITAL MANAGEMENT, LLC | 6,885,361 | 1,331,164,666 | 3.29 |
| FRANKLIN RESOURCES INC | 5,472,003 | 1,061,951,604 | 2.63 |
| WELLINGTON MANAGEMENT GROUP LLP | 5,299,030 | 1,028,382,752 | 2.54 |
| Clearbridge Investments, LLC | 4,092,337 | 794,199,928 | 1.97 |
| Invesco Ltd. | 3,790,490 | 735,620,464 | 1.82 |
| NORGES BANK | 3,783,792 | 734,320,513 | 1.82 |
| JPMORGAN CHASE & CO | 3,499,218 | 679,093,485 | 1.68 |
| MORGAN STANLEY | 3,374,640 | 654,916,597 | 1.62 |
| AMERICAN CENTURY COMPANIES INC | 3,129,651 | 607,371,852 | 1.50 |
| Veritas Asset Management LLP | 2,874,579 | 557,869,547 | 1.38 |
| HARRIS ASSOCIATES L P | 2,841,721 | 551,492,794 | 1.36 |
| BANK OF AMERICA CORP /DE/ | 2,813,314 | 545,979,796 | 1.35 |
| NORDEA INVESTMENT MANAGEMENT AB | 2,773,058 | 541,328,651 | 1.34 |
| NORTHERN TRUST CORP | 2,504,289 | 486,007,365 | 1.20 |
| DIMENSIONAL FUND ADVISORS LP | 2,405,430 | 466,857,642 | 1.16 |